$1.43
-0.03 (-2.05%)
Analyst Consensus
Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,271.3% upside
Low Target
$14.26
Average Target
$19.61
High Target
$29.32
Current Price
$1.43
Current
$1.43
$1.43
Target
$19.61
$19.61
$14.26
$19.61 avg
$29.32
Scenario Analysis
Bear Case
$14.26
897.2%
Low target
Base Case
$19.61
+1,271.3%
Avg target
Bull Case
$29.32
+1,950.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$2.72
-47.4% from high
52-Week Low
$0.56
+153.9% from low
Target vs 52W High
$19.61
+621.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.2% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.1% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -17.6% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -30.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -50.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -31.6% |